温州医科大学附属眼视光医院玻璃体切割术 适应证及术式10年变化趋势

doi::10.3760/cma.j.cn115909-20210603-00227

摘要
图/表
参考文献(37)
相关文章 (15)

全文: PDF 1129KB HTML (1 KB)
输出: BibTeX | EndNote (RIS) 背景资料

文章导读

摘要目的：探讨温州医科大学附属眼视光医院2010年至2019年间玻璃体切割术适应证及术式的变化趋势。
方法：回顾性系列病例研究。纳入2010年1月1日至2019年12月31日在温州医科大学附属眼视光医院行玻璃体切割手术的病例22 491例，其中男12 287例，女10 204例，年龄1～95岁。根据玻璃体切割手术适应证（视网膜脱离、糖尿病视网膜病变、黄斑病变、眼外伤、无视网膜脱离的玻璃体视网膜疾病、晶状体病变及其他眼病）、手术类型（前段玻璃体切割术、单纯玻璃体切割术及玻璃体切割联合晶状体手术）及玻璃体腔填充物（气体、硅油及其他液体）进行分类，对上述适应证、手术方式变化趋势及患者的人口学资料进行统计学描述。
结果：温州医科大学附属眼视光医院玻璃体切割术年手术量由2010年的1 398例逐渐增加至2019年的3 791例。患者年龄由2010年的（50.1±16.4）岁上升至2019年的（57.2±14.5）岁，以男性为多，但女性比例逐年增加（由2010年的39.7%增至2019年的46.6%）。2010年至2019年间，前4位玻璃体切割术适应证依次为视网膜脱离（29.4%），黄斑疾病（22.0%），糖尿病视网膜病变（19.7%）及眼外伤（15.5%）。因黄斑疾病接受手术的患者数量及构成比逐年增多，由2010年的195例（14.0%）增加至2019年的1 054例（27.8%），已成为玻璃体切割术的首位适应证。手术类型方面，玻璃体切割联合晶状体手术为13 896例（61.8%），所占的比例明显上升（2010年55.2%，2019年69.0%）。玻璃体腔填充物方面，气体及硅油是玻璃体切割术后的主要填充物（2010年占83.4%，2019年占74.9%）。近5年硅油填充比例较前5年下降（2010─2014年期间占 40.2%～43.8%，2015─2019年期间占34.1%～39.6%）。
结论：2010─2019年温州医科大学附属眼视光医院玻璃体切割手术的主要适应证为视网膜脱离、黄斑疾病、糖尿病视网膜病变。其中黄斑疾病占比逐年增加。玻璃体切割联合晶状体手术已成为主流术式。10年来玻璃体切割术后硅油填充的使用比例在逐渐下降。

	服务

	把本文推荐给朋友
	加入我的书架
	加入引用管理器
	E-mail Alert
	RSS
	作者相关文章
	江俊宏
	吴荣瀚
	郑思思
	等

关键词 ：

Abstract：Objective: To analyze trends in indications and surgical techniques for vitrectomy in the Eye Hospital, Wenzhou Medical University from 2010 to 2019. Methods: This was a retrospective case series study. 22 491 patients who underwent vitrectomy, aged from 1 to 95 years, in the Eye Hospital, Wenzhou Medical University were enrolled from January 2010 to July 2019. There were 12 287 males and 10 204 females. The indications (retinal detachment, diabetic retinopathy, maculopathy, ocular trauma, vitreoretinopathy without retinal detachment, lens lesions and other oculopathies), surgical procedures (anterior vitrectomy, vitrectomy alone and vitrectomy combined with lens surgery) and vitreous substitutes (gas, silicone oil and other liquids) for vitrectomy were collected. Patient demographics, indications and types of vitrectomy performed were evaluated. SPSS 21.0 statistical software was used, mainly for a statistical description of the data. Results: The numbers of annual surgeries performed at the Eye Hospital, Wenzhou Medical University for vitrectomy were 1 398 cases in 2010, rising gradually to 3 791 cases in 2019. The mean age of patients who underwent vitrectomy was 50.1±16.4 years in the 2010 s, rising gradually to 57.2±14.5 years in the 2019 s. Macular disease in vitrectomy patients had increased rapidly over the ten years. There was a higher proportion of male patients compared to females, while the proportion of females had increased gradually (2010, 39.7%; 2019, 46.6%). Retinal detachment (29.4%), maculopathy (22.0%), diabetic retinopathy (19.7%) and ocular trauma (15.5%) were the top 4 indications for vitrectomy between 2010 and 2019. The number and proportion of patients undergoing vitrectomy for maculopathy increased year by year. Vitrectomies for maculopathy were performed on 195 cases (14.0%) in the 2010 s, and frequency reached 1 054 cases (27.8%) in the 2019 s. Maculopathy has become the first indication for vitrectomy. For the type of vitrectomy, 13 896 cases (61.8%) were vitrectomy combined with lens surgery, which had been increasing since 2010 (2010, 55.2%; 2019, 69.0%). In the vitreous substitute of vitrectomy, gas and silicone oil were the main vitreous substitutes after vitrectomy (2010, 83.4%; 2019, 74.9%). The proportion of silicone oil decreased in the latter 5 years (2010 to 2014 ranged from 40.2% to 43.8%; 2015 to 2019 ranged from 34.1% to 39.6%). Conclusions: Retinal detachment, maculopathy and diabetic retinopathy from ocular trauma were the leading indications for vitrectomy, and maculopathy increased rapidly in the Eye Hospital, Wenzhou Medical University from 2010 to 2019. Vitrectomy combined with lens surgery is becoming the mainstream procedure for vitrectomy and the proportion of silicone oil used for filling decreased gradually over the 10 years.

Key words： vitreoretinopathy vitrectomy indication vitreous substitute

收稿日期: 2021-06-03

PACS:

玻璃体视网膜疾病|玻璃体切割术|适应证|玻璃体腔填充物

基金资助:浙江省自然科学基金青年基金（LQ18H120004）；温州市基础性医疗卫生科技项目（Y2020364）

通讯作者: 林仲（ORCID：0000-0002-4828-7157），Email：linzhong_@126.com

引用本文:

江俊宏, 吴荣瀚, 郑思思, 等. 温州医科大学附属眼视光医院玻璃体切割术适应证及术式10年变化趋势[J]. 中华眼视光学与视觉科学杂志, 2022, 24(1): 10-16. Junhong Jiang, Ronghan Wu, Sisi Zheng, et al. Trends in Indications and Surgical Techniques for Vitrectomy of the Eye Hospital, Wenzhou Medical University during a Recent Ten-Year Period. Chinese Journal of Optometry Ophthalmology and Visual science, 2022, 24(1): 10-16. DOI: :10.3760/cma.j.cn115909-20210603-00227

链接本文:

https://www.cjoovs.com/CN/:10.3760/cma.j.cn115909-20210603-00227 或 https://www.cjoovs.com/CN/Y2022/V24/I1/10

[1]	Flaxman SR, Bourne RRA, Resnikoff S, et al. Global causes of blindness and distance vision impairment 1990-2020: a systematic review and meta-analysis. Lancet Glob Health, 2017,5(12): e1221-e1234. DOI: 10.1016/S2214-109X(17)30393-5.
[2]	许迅, 黎晓新. 眼底病研究进展及展望. 中华眼科杂志, 2007,43(3): 281-283. DOI: 10.3760/j.issn:0412-4081.2007.03.021.
[3]	Zhao J, Xu X, Ellwein LB, et al. Causes of visual impairment and blindness in the 2006 and 2014 nine-province surveys in rural China. Am J Ophthalmol, 2019, 197: 80-87. DOI: 10.1016/j.ajo.2018.09.011.
[4]	Machemer R, Buettner H, Norton EW, et al. Vitrectomy: a pars plana approach. Trans Am Acad Ophthalmol Otolaryngol, 1971,
75	(4): 813-820.
[5]	吴辉, 陶海, 吴海洋. 微创玻璃体手术的研究进展. 中华眼底病杂志, 2009, 25(1): 72-75. DOI: 10.3760/cma.j.issn.1005-1015.2009.01.024.
[6]	黎晓新, 赵明威. 我国近五年眼底病诊疗技术进展. 中华眼科杂志, 2010, 46(10): 900-905. DOI: 10.3760/cma.j.issn.0412-
40	81.2010.10.006.
[7]	中华医学会眼科学分会眼底病学组. 我国眼底病近五年十大研究进展. 中华眼科杂志, 2014, 50(11): 839-842. DOI:10.3760/cma.j.issn.0412-4081.2014.11.008.
[8]	O'Malley C, Heintz RM. Vitrectomy via the pars plana--a new instrument system. Trans Pac Coast Otoophthalmol Soc Annu
	Meet, 1972, 53: 121-137.
[9]	Fujii GY, De Juan E Jr, Humayun MS, et al. A new 25-gauge instrument system for transconjunctival sutureless vitrectomy surgery. Ophthalmology, 2002, 109(10): 1807-1812; discussion 1813. DOI: 10.1016/s0161-6420(02)01179-x.
[10]	Eckardt C. Transconjunctival sutureless 23-gauge vitrectomy. Retina, 2005, 25(2): 208-211. DOI: 10.1097/00006982-200502000-00015.
[11]	Oshima Y, Wakabayashi T, Sato T, et al. A 27-gauge instrument system for transconjunctival sutureless microincision vitrectomy
	surgery. Ophthalmology, 2010, 117(1): 93-102.e2. DOI:10.1016/j.ophtha.2009.06.043.
[12]	李杰, 刘三梅, 李芳, 等. 27G微创玻璃体切除手术的发展及应用. 国际眼科杂志, 2016, 16(8): 1483-1486. DOI: 10.3980/j.issn.1672-5123.2016.8.20.
[13]	陈焓, 李志洪, 董晓光. 10年3 888例玻璃体切除手术流行病学调查研究. 医学信息(中旬刊), 2011, 24(2): 397-399. DOI:10.3969/j.issn.1006-1959.2011.02.032.
[14]	El-Amir AN, Keenan TD, Abu-Bakra M, et al. Trends in rates of retinal surgery in England from 1968 to 2004: studies of hospital
	statistics. Br J Ophthalmol, 2009, 93(12): 1585-1590. DOI:10.1136/bjo.2009.159939.
[15]	Kim JY, Rim TH, Kim SS. Trends of pars plana vitrectomy rates in South Korea: a nationwide cohort study. Korean J Ophthalmol,2017, 31(5): 446-451. DOI: 10.3341/kjo.2016.0070.
[16]	Wubben TJ, Talwar N, Blachley TS, et al. Rates of vitrectomy among enrollees in a United States managed care network,2001-2012. Ophthalmology, 2016, 123(3): 590-598. DOI:10.1016/j.ophtha.2015.11.001.
[17]	Jin G, Ding X, Xiao W, et al. Prevalence of age-related macular degeneration in rural southern China: the Yangxi Eye Study.
	Br J Ophthalmol, 2018, 102(5): 625-630. DOI: 10.1136/bjophthalmol-2017-310368.
[18]	Zou H, Zhang X, Xu X, et al. Epidemiology survey of rhegmatogenous retinal detachment in Beixinjing District, Shanghai, China. Retina, 2002, 22(3): 294-299. DOI:10.1097/00006982-200206000-00007.
[19]	林惠芳. 2011-2015 年嘉兴市中医医院眼科住院患者病种分析. 中国医院统计, 2017, 24(3): 231-233. DOI: 10.3969/j.issn.1006-5253.2017.03.024.
[20]	McCannel CA, Ensminger JL, Diehl NN, et al. Population-based incidence of macular holes. Ophthalmology, 2009, 116(7):1366-1369. DOI: 10.1016/j.ophtha.2009.01.052.
[21]	Du R, Xie S, Igarashi-Yokoi T, et al. Continued increase ofaxial length and its risk factors in adults with high myopia.JAMA Ophthalmol, 2021, 139(10): 1096-1103. DOI: 10.1001/jamaophthalmol.2021.3303.
[22]	林瑶瑶, 梁优萍, 周文哲, 等. 温州地区眼外伤患者分布特征研究. 中华眼外伤职业眼病杂志, 2018, 40(5): 375-378. DOI:10.3760/cma.j.issn.2095-1477.2018.05.014.
[23]	Sayanagi K, Sharma S, Yamamoto T, et al. Comparison of spectral-domain versus time-domain optical coherence tomography in management of age-related macular degeneration with ranibizumab. Ophthalmology, 2009, 116(5): 947-955. DOI:10.1016/j.ophtha.2008.11.002.
[24]	汪枫桦, 孙晓东, 许迅. 老年性黄斑变性不同分期的光相干断层扫描图像特征. 中华眼底病杂志, 2012, 28(3): 295-297.DOI: 10.3760/cma.j.issn.1005-1015.2012.03.023.
[25]	陶继伟, 褚梦琪, 王奇骅, 等. 术中OCT在致密玻璃体积血玻璃体切割手术中的应用. 中华眼视光学与视觉科学杂志, 2017, 19(11): 686-690. DOI: 10.3760/cma.j.issn.1674-845X.2017.11.010.
[26]	陶继伟, 陈焕, 沈丽君, 等. 玻璃体切割联合内界膜剥除和空气填充治疗特发性黄斑裂孔. 中华眼视光学与视觉科学杂志, 2019, 21(6): 439-443. DOI: 10.3760/cma.j.issn.1674-845X.2019.06.007.
[27]	赵士鑫, 吴韩飞, 沈丽君, 等. 玻璃体切割联合内界膜剥除治疗糖尿病性黄斑水肿. 中华眼视光学与视觉科学杂志, 2019,21(6): 433-438. DOI: 10.3760/cma.j.issn.1674-845X.2019.06.006.
[28]	雒文娟, 陶明, 李艳, 等. 内界膜填塞联合空气填充术治疗大直径特发性黄斑裂孔. 中华眼视光学与视觉科学杂志, 2021,23(4): 247-253. DOI: 10.3760/cma.j.cn115909-20200909-00362.
[29]	Melberg NS, Thomas MA. Nuclear sclerotic cataract after vitrectomy in patients younger than 50 years of age.Ophthalmology, 1995, 102(10): 1466-1471. DOI: 10.1016/s0161-6420(95)30844-5.
[30]	Thompson JT, Glaser BM, Sjaarda RN, et al. Progression of nuclear sclerosis and long-term visual results of vitrectomy with transforming growth factor beta-2 for macular holes.Am J Ophthalmol, 1995, 119(1): 48-54. DOI: 10.1016/s0002-9394(14)73812-7.
[31]	Freeman WR, Azen SP, Kim JW, et al. Vitrectomy for the treatment of full-thickness stage 3 or 4 macular holes.Results of a multicentered randomized clinical trial. The Vitrectomy for Treatment of Macular Hole Study Group.Arch Ophthalmol, 1997, 115(1): 11-21. DOI: 10.1001/archopht.1997.01100150013002.
[32]	Lahey JM, Francis RR, Fong DS, et al. Combining phacoemulsification with vitrectomy for treatment of macularholes. Br J Ophthalmol, 2002, 86(8): 876-878. DOI: 10.1136/bjo.86.8.876.
[33]	Gottlieb CC, Martin JA. Phacovitrectomy with internal limiting membrane peeling for idiopathic macular hole. CanJ Ophthalmol, 2002, 37(5): 277-282, discussion 82. DOI:10.1016/s0008-4182(02)80022-9.
[34]	韩钰, 王军. 微小切口白内障手术新进展. 中华眼科杂志,2012, 35(4): 369-373. DOI: 10.3760/cma.j.issn.0412-4081.2012.04.021.
[35]	Kellner U, Lucke K, Foerster MH. Effect of intravitreal liquid silicone on optic nerve function. Am J Ophthalmol, 1988,106(3): 293-297. DOI: 10.1016/0002-9394(88)90364-9.
[36]	Ando F, Miyake Y, Oshima K, et al. Temporary use of intraocular silicone oil in the treatment of complicated retinal detachment. Graefes Arch Clin Exp Ophthalmol, 1986, 224(1):32-33. DOI: 10.1007/BF02144129.
[37]	Miller JB, Papakostas TD, Vavvas DG. Complications of emulsified silicone oil after retinal detachment repair. Semin Ophthalmol, 2014, 29(5-6): 312-318. DOI: 10.3109/08820538.2014.962181.